US Stock MarketDetailed Quotes

UNCY Unicycive Therapeutics

Watchlist
  • 1.0700
  • -0.0200-1.83%
Close Apr 19 16:00 ET
  • 1.0500
  • -0.0200-1.87%
Post 18:15 ET
37.19MMarket Cap-835P/E (TTM)

About Unicycive Therapeutics Company

Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Company Profile

SymbolUNCY
Company NameUnicycive Therapeutics
Listing DateJul 13, 2021
Issue Price5.00
Founded2016
CEODr. Shalabh Gupta, M.D.
MarketNASDAQ
Employees14
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4300 El Camino Real,Suite 210
CityLos Altos
ProvinceCalifornia
CountryUnited States of America
Zip Code94022
Phone1-650-351-4495
Websitehttp://www.unicycive.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Shalabh Gupta, M.D.
  • Chief Executive Officer, President and Chairman of the Board
  • 1.51M
  • John W. Townsend
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Douglas Jermasek
  • Executive Vice President, Corporate Strategy
  • 465.17K
  • Dr. Pramod Gupta, M.D.
  • Executive Vice President, Pharmaceutical and Business Operations
  • 796.67K
  • Dr. Gaurav Aggarwal, M.D.
  • Director
  • --
  • Dr. Sandeep Laumas, M.D.
  • Independent Director
  • 60.00K
  • Dr. Saraswati Kenkare-Mitra, PhD
  • Independent Director
  • --
  • Dr. John Ryan, M.D.,PhD
  • Independent Director
  • 63.06K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg